July 08, 2021
Features
41
7
With small biotechs facing similar expectations as large pharma in drug safety and pharmacovigilance, despite less resources, identifying the key differences between US and EU requirements can help these companies craft a practical path to multi-region compliance.
July 08, 2021
Features
41
7
Seeking opportunities to be more inclusive can help pharma companies gain a deeper understanding of key opinion leader and patient perspectives and build diversity into the entire product journey.
July 08, 2021
Features
41
7
Latino executives share their experiences and insights on the community’s contributions to the life sciences industry.
July 08, 2021
Features
41
7
Along with the industry’s massive effort to tackle the health and social problems exposed by COVID, pharma companies have spent the last year addressing the internal impact of racial inequalities following the murder of George Floyd.
July 08, 2021
Executive Profile
41
7
Influenced by lessons from the playing field, former rugby athlete James Robinson, today president and CEO of Urovant Sciences, discusses the keys to establishing a high-performing team culture in biopharma—and the end-game wins in treatment gain and patient need.
July 08, 2021
Finance
41
7
A remarkable run indeed, but cost questions can’t be ignored.
July 08, 2021
Technology
41
7
Closing the gaps in complex therapy data remains a hurdle, but “getting clever” with AI can offer a path forward.
July 08, 2021
Leadership
41
7
Give your team members opportunities to lead for greater growth.
July 08, 2021
Europe Report
41
7
Summits, proposals outline advice on response to future pandemics.
July 08, 2021
Washington Report
41
7
White House backs big boost in funding for research, public health.
July 08, 2021
From the Editor
41
7
Recent roundtable highlights need for biopharma to enter ESG conversation.
July 08, 2021
Chairman’s Letter
41
7
Debate on origin of virus responsible for global pandemic continues on.
July 08, 2021
Issue PDF
41
7
Click the title above for a link to open the Pharmaceutical Executive July 2021 issue in an interactive PDF format.
June 09, 2021
Back Page
41
7
Commercial-model shift demanding greater influence of these teams.
May 13, 2021
Features
41
7
The eight key areas biopharma manufacturers must stay on top of when planning and executing alliance agreements with prospective digital health partners.